Your Cart is Empty
The founder and CEO of Dry Eye Drink. Doctor Davidson runs one of the largest dry eye clinics in the American South.
Dr Joshua Davidson grew up in Bay City Michigan where, from the age of 11, he had his eyes set on Optometry. Dr Davidson graduated from All Saints Catholic Central and attended The University of Michigan in Ann Arbor as an undergraduate where he graduated with a degree in Biology. He went on to complete his Doctor of Optometry (OD) degree at the Michigan College of Optometry. Dr. Davidson’s clinical rotations included The William Dorn VA in Columbia, South Carolina, Anderson Eye Associates in Saginaw Michigan, and the Duane L Waters Hospital at the Michigan Department of Corrections Maximum Security Prison in Jackson, Michigan.
Dr. Davidson’s interests are in the areas of dry eye treatment, speciality contact lenses, and ocular disease. In his spare time, he enjoys CrossFit, playing softball, traveling, watching college football (his beloved Michigan Wolverines and his adopted LSU Tigers), and spending time with his son, Brooks.
In October 2019 Dr. Davidson attained the highest status in the profession of Optometry, that of Fellow of the American Academy of Optometry (FAAO). In qualifying and maintaining this fellowship, individuals are evaluated against the highest standards of professional competence.
Dr. Davidson is also proud to be a fellow of the Scleral Lens Education Society (FSLS). He is currently the only certified “expert” scleral lens fitter in all of Louisiana, Mississippi, or Arkansas. His interests lie in fitting all speciality contact lenses for high prescriptions, multifocal “bifocal” contacts, keratoconus, post-radial keratotomy, post LASIK, dry eye, amongst countless other ocular issues. More information can be found at http://sclerallens.org/scleral-fitters
Dr. Davidson serves on the medical advisory board and is a paid speaker for Eyevance Pharmaceuticals (https://eyevance.com/) and Kala Pharmaceuticals (https://kalarx.com/), and serves as a medical advisor for Allergan/Abbvie He is on the editorial board of Modern Optometry magazine, and is a consultant of Glaukos Corporation. Recently, Dr. Davidson was given the honor of serving as part of the American Optometric Association’s (AOA) inaugural Leadership Institute.
Dr Matthew D. Smith is a board-certified ophthalmicphysician and surgeon at the Williamson Eye Center in Baton Rouge, Louisiana. Dr. Smith specializes in cataract and refractive surgery, treating glaucoma patients, and performing glaucoma surgery.
Dr. Smith is a native of Baton Rouge, Louisiana graduating with honours from Catholic High School and Magnum Cum Laude from LSU with a B.S. degree in Biological Sciences with a pre-med focus.
Dr. Smith later graduated the top one-third of his class at LSU Medical School in Shreveport and was accepted into one of the most competitive residencies, Ophthalmology at LSU. Dr. Smith completed his first year of residency at the University of Tennessee Medical Center in Knoxville returning to Shreveport and finishing as chief resident in 2013. He was awarded the Southern Medical Association Scholarship Award. He is currently a member of the American Academy of Ophthalmology, enabling him to stay at the leading edge of the ophthalmology professional practice.
In addition to being a member of the American Academy of Ophthalmology, Dr. Smith currently volunteers for the Project Purr and Cat Haven organizations. He has been involved with volunteering since his youth, starting as an Eagle Scout and participating in supporting the local chapter of The Missionaries of Charity, assisting the nuns in the care of the less fortunate. When Dr. Smith isn’t volunteering, he enjoys LSU sports, bowling, spending time with friends and family, and is an avid Chicago Cubs and New Jersey Devils hockey fan.
Charles H. Williamson Jr is the Administrator of Williamson Eye Center and co-owner of Williamson Management, LLC and Williamson Eyewear. After spending most of his college and graduate school years in investment banking, Mr Williamson embarked on a career in healthcare management with his father’s business at Williamson Eye Center. A native of Baton Rouge, he earned his B.S. in International Trade and Finance with a Minor in Economics at Louisiana State University, and a dual Masters Degree from the University of Houston in Business and Healthcare Administration, graduating in December of 2001.
Mr. Williamson also works extensively in the entrepreneurship space in the area of synergizing healthcare benefit offerings with professional service software management platforms; new ophthalmic technology introductions to the US Market; and, biologic therapy offerings to eye care networks.
In 2007, he created a virtual optical dispensary called 25 Dollar Eyeglasses
(www.25dollareyeglasses.com), whereby, customers from across the United States could purchase prescription eyeglasses at the most affordable prices available. At the same time, Mr. Williamson was a key contributing partner in developing US Hearing Plan (www.ushearingplan.com), which provided the hearing impaired with access to hearing health professionals and hearing aid products at significantly reduced prices.
Recently, Mr. Williamson and several other partners created “Marucci Eyewear” for Marucci Sports, Inc, a brand leader in the sport of baseball. His company has global sales rights for the sale of Marucci Eyewear to physician practices, optical chains, and other retailers.
Outside of business, Mr. Williamson sits on several Advisory Councils healthcare software companies and is one of nine committee members working for the Louisiana State Supreme court on the Louisiana Attorney Disciplinary Board.
Mr. Williamson and his wife Meeta reside in Baton Rouge with their three children Charlie, Ethan, and Alayna. In his spare time, he enjoys cooking, travel, golf and spending time with his family.
With over 20 years experience running some of the largest dry eye clinics in the
United States, Dr. Karpecki is a leader and pioneer in this dedicated area of
optometry. He is a noted educator and author, having delivered over 1000 lectures and authored over 1000 papers on the subject of Dry Eye Disease - a condition that can negatively affect not only a patient’s vision but also their quality of life.
In 2002, Dr. Karpecki was named to the National Eye Institute’s Dry Eye Committee to provide insights into the condition and its effects on women, in particular. In 2003, he was appointed to the Delphi International Society at Wilmer-Johns Hopkins, which put him in the company of the top 25 Dry Eye experts in the world.
He currently serves as the Chief Clinical Editor for Review of Optometry, the most read journal in the profession. He is the Director of Clinical Content, as well as Chairman, of the New Technology and Treatment Conferences, and serves on the board for the charitable organization Optometry Giving Sight. Dr. Karpecki has also served as Co-Chair for the optometry profession’s Dry Eye Summit, Director for the CJO Optometric Dry Eye Guidelines for EyeCare, and Committee Member for the DEWS II Diagnostic sub-committee. Most recently, he was appointed Co-Chair of the Tear Film and Ocular Surface Society Symposium in 2016 in Montpellier, France. Dr. Karpecki is dedicated to making a substantial impact in the quality and consistency of dry eye patient care in the Louisville community.
Dr. Karpecki received his doctor of optometry degree from Indiana University before completing a fellowship in medical cornea and refractive surgery at Pennsylvania College of Optometry. In addition to his responsibilities with Gaddie, he also currently serves as Clinical Director of Advanced Ocular Surface Disease at Kentucky Eye Institute. He lives in Lexington with his wife, Chandria, and their three children.
Dr Barry Schechter has written over 20 peer reviewed scientific journal articles and is a featured speaker on Ophthalmologic "front of the eye" diseases such as dry eye, corneal ulcers, tumors and corneal transplantation.He has presented papers in Europe, Asia, South and North America. He is a consultant for Bausch, Sun Pharma, Santen and on the executive board of Innovation Pharmaceuticals and Aperta biosciences.